Literature DB >> 10928331

Botulinum toxin C3 inhibits hyperalgesia in mice with partial sciatic nerve injury.

X Ye1, M Inoue, H Ueda.   

Abstract

Mice with partial ligation of the sciatic nerve exhibited marked increase in the second phase nociceptive biting and licking behavior following intraplantar injection of formalin. The intrathecal pretreatment with botulinum toxin C3 dose-dependently attenuated the hyperalgesia in the second phase. These results suggest that a small G protein, Rho, and its downstream mechanisms are involved in the hyperalgesia following partial nerve injury.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10928331     DOI: 10.1254/jjp.83.161

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  3 in total

1.  Involvement of lysophosphatidic acid in bone cancer pain by potentiation of TRPV1 via PKCε pathway in dorsal root ganglion neurons.

Authors:  Hai-Li Pan; Yu-Qiu Zhang; Zhi-Qi Zhao
Journal:  Mol Pain       Date:  2010-12-01       Impact factor: 3.395

Review 2.  Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies.

Authors:  Luiz Henrique Medeiros Geraldo; Tânia Cristina Leite de Sampaio Spohr; Rackele Ferreira do Amaral; Anna Carolina Carvalho da Fonseca; Celina Garcia; Fabio de Almeida Mendes; Catarina Freitas; Marcos Fabio dosSantos; Flavia Regina Souza Lima
Journal:  Signal Transduct Target Ther       Date:  2021-02-01

Review 3.  Peripheral mechanisms of neuropathic pain - involvement of lysophosphatidic acid receptor-mediated demyelination.

Authors:  Hiroshi Ueda
Journal:  Mol Pain       Date:  2008-04-01       Impact factor: 3.395

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.